Condition
Advanced Gastric Adenocarcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Advanced Gastric Adenocarcinoma clinical trials that are recruiting, at sites in 6 countries (most in United States (2), France (1), Puerto Rico (1)). By phase: Phase 2/3 (2), Phase 2 (1), Phase 3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 6Countries
Newest Advanced Gastric Adenocarcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Dual-target CAR-NK therapy against CLDN18.2 and HER2 for advanced stomach/GEJ cancer | Phase 1/2 | Shenzhen, Guangdong | Recruiting | Apr 24, 2026 |
| Ivonescimab plus chemotherapy for advanced or metastatic gastric and gastroesophageal adenocarcinoma | Phase 2 | Lyon and 3 other locations | Recruiting | Feb 26, 2025 |
| Combining Nivolumab with Standard Treatment for Advanced Stomach or Esophageal Cancer | Phase 2/3 | Little Rock, Arkansas and 377 other locations | Recruiting | Jan 12, 2024 |
| Total neoadjuvant chemotherapy for advanced gastric and gastroesophageal cancer | Phase 2/3 | Vilnius and 1 other locations | Recruiting | Sep 8, 2023 |
| Comparing two chemotherapy regimens for advanced HER2 negative gastric and esophageal cancer | Phase 3 | Birmingham, Alabama and 801 other locations | Recruiting | Jan 10, 2023 |
All recruiting trials (5)
-
Dual-target CAR-NK therapy against CLDN18.2 and HER2 for advanced stomach/GEJ cancer
This trial will test an off-the-shelf, cord-blood-derived CAR-NK cell therapy that targets CLDN18.2 and HER2 in adults with unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma who have progressed after at least two prior treatments.
-
Ivonescimab plus chemotherapy for advanced or metastatic gastric and gastroesophageal adenocarcinoma
This trial tests whether adding ivonescimab to standard chemotherapy helps adults with advanced or metastatic gastric or gastroesophageal adenocarcinoma respond better to treatment.
-
Combining Nivolumab with Standard Treatment for Advanced Stomach or Esophageal Cancer
This study is testing if adding nivolumab to the usual treatments for advanced stomach or esophageal cancer can help patients live longer and feel better.
-
Total neoadjuvant chemotherapy for advanced gastric and gastroesophageal cancer
This study is testing two different chemotherapy plans for people with advanced stomach cancer to see which one helps them better tolerate treatment and successfully have surgery.
-
Comparing two chemotherapy regimens for advanced HER2 negative gastric and esophageal cancer
This study is testing if a new chemotherapy combination can help people with advanced HER2 negative stomach and esophageal cancer live longer compared to the standard treatment.
Related topics
Quick answers
How many Advanced Gastric Adenocarcinoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (2 trials), France (1 trial), Puerto Rico (1 trial), China (1 trial), Lithuania (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 2, Phase 2: 1, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.